Cargando…
Human Cytomegalovirus Antigens in Malignant Gliomas as Targets for Adoptive Cellular Therapy
Malignant gliomas are the most common primary brain tumor in adults, with over 12,000 new cases diagnosed in the United States each year. Over the last decade, investigators have reliably identified human cytomegalovirus (HCMV) proteins, nucleic acids, and virions in most high-grade gliomas, includi...
Autores principales: | Landi, Daniel, Hegde, Meenakshi, Ahmed, Nabil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4244608/ https://www.ncbi.nlm.nih.gov/pubmed/25505736 http://dx.doi.org/10.3389/fonc.2014.00338 |
Ejemplares similares
-
Adoptive Cell Therapies for Glioblastoma
por: Bielamowicz, Kevin, et al.
Publicado: (2013) -
Chimeric Antigen Receptor Based Cellular Therapy for Treatment Of T-Cell Malignancies
por: Polgárová, Kamila, et al.
Publicado: (2022) -
Common Molecular Alterations in Canine Oligodendroglioma and Human Malignant Gliomas and Potential Novel Therapeutic Targets
por: Mitchell, Dana, et al.
Publicado: (2019) -
IMMU-16. IDENTIFICATION OF TUMOR REJECTION ANTIGENS FOR PRECISION ADOPTIVE CELLULAR THERAPY FOR PEDIATRIC GLIOMAS
por: Trivedi, Vrunda, et al.
Publicado: (2023) -
Targeting FGL2 in glioma immunosuppression and malignant progression
por: Ma, Xiaoyu, et al.
Publicado: (2022)